Learn
Medical EducationEvidence-Based MedicinePatient Education
ICU Toolkit
CalculatorsProtocols & CardsICU Setup
CPT & BillingZad TalkForumContact
Home / Calculators / IABP-SHOCK II Risk Score Calculator

IABP-SHOCK II Risk Score Calculator

Predicts 30-day mortality in cardiogenic shock complicating acute myocardial infarction, from six variables available on admission and after PCI.

IABP-SHOCK II Score
Fill in the fields above to see the result.

How to read the result

ScoreRisk30-day mortality, derivationShort-term mortality, CardShock
0-2Low23.8%28.0%
3-4Intermediate49.2%42.9%
5-9High76.6%77.3%

The score should not decide mechanical circulatory support, escalation or limitation of care on its own.

Scoring

VariablePoints
Age older than 73 years1
Prior stroke2
Glucose on admission above 191 mg/dL (10.6 mmol/L)1
Creatinine on admission above 1.5 mg/dL (132.6 µmol/L)1
Arterial lactate on admission above 5 mmol/L2
TIMI flow grade below 3 after PCI2

Validation

Derived in the IABP-SHOCK II trial (infarct-related cardiogenic shock with early revascularization) and validated in the IABP-SHOCK II registry (AUC 0.79) and the CardShock cohort (AUC 0.73). Among patients from CULPRIT-SHOCK it discriminated best of the scores compared (AUC 0.74, against 0.69 for CardShock). In the North American CCCTN registry it showed a three-fold mortality gradient in AMI shock (c-statistic 0.67) and in other shock types. It is built for infarct-related shock and needs the TIMI flow after PCI.

References

  1. Pöss J, Köster J, Fuernau G, et al. Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69(15):1913-1920. PMID 28408020
  2. Freund A, Pöss J, de Waha-Thiele S, et al. Comparison of risk prediction models in infarct-related cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2021;10(8):890-897. PMID 34529043
  3. Alviar CL, Li BK, Keller NM, et al. Prognostic performance of the IABP-SHOCK II risk score among cardiogenic shock subtypes in the Critical Care Cardiology Trials Network registry. Am Heart J. 2024;270:1-12. PMID 38190931
Keep reading

Related articles

All Cardiovascular →